Gerresheimer completes Centor sale: Gerresheimer stock sits 27.11 percent below its high

Published on 10/05/2026 at 12:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue hit EUR 578 million, up 10.52 percent from the first quarter. Gerresheimer stock costs EUR 27.93 on October 5, 2026 versus EUR 27.55.

Automatisierte Glasampullen-Produktionslinie in steriler Pharmafabrik — Gerresheimer AG mit ISIN DE000A0LD6E6 produziert Glasampullen in hochautomatisierter, steriler Pharmaverpackungsfertigung mit modernster Anlagentechnik, Illustration mit AI erstellt.

Gerresheimer (ISIN DE000A0LD6E6) was trading at EUR 27.93 at Lang & Schwarz on October 5, 2026 at 12:19 p.m. CEST, plus 1.38 percent versus the prior close of EUR 27.55. That price is 27.11 percent below the EUR 38.32 52-week high. On October 1, 2026, FT.com reported that Gerresheimer completed the sale of Centor.

Centor sale shifts debt picture

The completed transaction transfers the U.S. subsidiary to funds advised by Apax Partners. Gerresheimer said the proceeds will be used to lower debt, while the sale of its Primary Packaging Plastics business is expected to close in the first half of 2027, according to FT.com.

Quarterly rebound meets weaker demand

Preliminary second-quarter 2026 revenue reached EUR 578.00 million, up EUR 55.00 million, or 10.52 percent, from the first quarter but down from EUR 614.00 million a year earlier. Adjusted EBITDA climbed to EUR 102.00 million from EUR 67.00 million sequentially, an increase of 52.24 percent, according to the September 30, 2026 results announcement published by FT.com.

The adjusted EBITDA margin improved to 17.60 percent in the second quarter of 2026, while first-half revenue totaled EUR 1.10 billion. The contrast matters: Containment and Delivery Systems generated EUR 308.00 million in second-quarter revenue, whereas Primary Injectable Solutions reported EUR 111.00 million, down from EUR 147.00 million a year earlier.

Balance sheet remains central

Jefferies kept a Hold rating and a EUR 26.80 price target on September 30, 2026, citing the stronger result against the first quarter but also higher net debt and lower liquidity, as reported by FinanzNachrichten. The target is EUR 1.13 below the Lang & Schwarz price, making leverage and the planned asset sales key valuation factors.

Stock stays below yearly high

Gerresheimer's EUR 27.93 Lang & Schwarz price on October 5, 2026 stood between the EUR 14.83 52-week low and EUR 38.32 high. The current quote therefore combines a 1.38 percent daily gain with a 27.11 percent gap to the yearly high.

The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.